Page last updated: 2024-10-22
amsacrine and Anemia
amsacrine has been researched along with Anemia in 1 studies
Amsacrine: An aminoacridine derivative that intercalates into DNA and is used as an antineoplastic agent.
amsacrine : A sulfonamide that is N-phenylmethanesulfonamide substituted by a methoxy group at position 3 and an acridin-9-ylamino group at position 4. It exhibits antineoplastic activity.
Anemia: A reduction in the number of circulating ERYTHROCYTES or in the quantity of HEMOGLOBIN.
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Sordillo, PP | 1 |
| Magill, GB | 1 |
| Gralla, RJ | 1 |
| Kelsen, DP | 1 |
Other Studies
1 other study available for amsacrine and Anemia
| Article | Year |
|---|---|
Phase II evaluation of 4'-(9-acridinylamino)-methanesulfon-m-anisidide (m-AMSA) in patients with gastric adenocarcinoma.
Topics: Adenocarcinoma; Aminoacridines; Amsacrine; Anemia; Antineoplastic Agents; Drug Evaluation; Humans; L | 1982 |